“…Although the medicinal components and efficacy of P. ginseng have been widely explored [8], [9], [10], [11], there is little information available on the genome of P. ginseng , making the molecular identification of different cultivars difficult. However, with the development of robust molecular markers, such as polymerase chain reaction (PCR)–restriction fragment length polymorphism [12], single-strand conformation polymorphism [13], randomly amplified polymorphic DNA [14], sequence-characterized amplified region [15], intersimple sequence repeat-derived sequence-characterized amplified region [16], amplification-refractory mutation system (ARMS) [17], amplified fragment length polymorphism, and directed amplification of minisatellite region DNA [18] for the Korean ginseng cultivars, this difficulty is prevailed.…”